Key Metrics
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
23%
4 to 6 months
74%
7 to 9 months
3%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Antigen
- Acetylcholine
- Janus kinase inhibitor
- Immune checkpoint inhibitors
- Food allergy
- Yersinia pestis
- Pulmonary pathology
- Chimeric antigen receptor
- Immunotherapy
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2390 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in IMMUNOTARGETS AND THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Harnessing Variability Signatures and Biological Noise May Enhance Immunotherapies' Efficacy and Act as Novel Biomarkers for Diagnosing and Monitoring Immune-Associated Disorders.
- 1 Oct 24
- ImmunoTargets and therapy
-
Full paper
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy.
- 1 Oct 24
- ImmunoTargets and therapy
-
Full paper
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma.
- 1 Oct 24
- ImmunoTargets and therapy
-
Full paper
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment.
- 1 Oct 24
- ImmunoTargets and therapy
-
Full paper
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study.
- 1 Sep 24
- ImmunoTargets and therapy
-
Full paper
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study.
- 1 Aug 24
- ImmunoTargets and therapy
Scite analysis
Powered by scite_
190 articles received 4k citations see all
- 56 Supporting
- 3,823 Mentioning
- 9 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 1 Errata
- 0 Expression of Concern
FAQs
How long has IMMUNOTARGETS AND THERAPY been actively publishing?
IMMUNOTARGETS AND THERAPY has been in operation since 2012 till date.
What is the publishing frequency of IMMUNOTARGETS AND THERAPY ?
IMMUNOTARGETS AND THERAPY published with a Continuous publication frequency.
How many articles did IMMUNOTARGETS AND THERAPY publish last years ?
In 2023, IMMUNOTARGETS AND THERAPY published 14 articles.
What is the eISSN & pISSN for IMMUNOTARGETS AND THERAPY ?
For IMMUNOTARGETS AND THERAPY,eISSN is 2253-1556 and pISSN is2253-1556.
Who is the publisher of IMMUNOTARGETS AND THERAPY ?
DOVE MEDICAL PRESS LTD is the publisher of IMMUNOTARGETS AND THERAPY.